But screening everyone who qualifies for Paxlovid, a drug designed to nip COVID in the bud, would take too much time and effort. And without study, many medical workers still aren’t sure who qualifies.
Original article: https://www.reviewjournal.com/livewell/covid-drug-vastly-underprescribed-data-suggests-2710989/
